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Summary.-A low-mol.-wt compound isolated from rat Walker 256 carcinoma and
found to induce neovascularization in vivo was tested on cultures of cow brain-
derived endothelial cells (CBEC) growing on plastic and collagen substrates.
This factor had a mitogenic effect on CBEC cultured on native collagen gels and for
this reason has been called "endothelial-cell-stimulating angiogenesis factor"
(ESAF). CBEC growing on plastic culture dishes or denatured collagen films were
not stimulated by ESAF.
The mitogenic effect of ESAF was equally apparent when added to cells already
attached to the native collagen substrate or when the collagen substrate was pre-
incubated with ESAF before plating the cells. A floating collagen gel pre-incubated
with ESAF in cultures of CBEC growing on plastic dishes did not stimulate cell
growth. Our data indicate that the substrate influences cell behaviour and that
CBEC only respond to ESAF when growing on a native collagen substrate.
THE GROWTH of a solid tumour depends
on the establishment of an adequate blood
supply (Algire & Chalkley, 1945; Folkman,
1974). This is accomplished by the in-
growth of new capillaries from the sur-
rounding host tissue in response to a
diffusible substance produced by tumour
cells and referred to as "tumour-angio-
genesis factor" or TAF (Folkman et al.,
1971). Partially purified tumour extracts
have been shown to contain angiogenic
activity by the induction of blood vessel
growth in various tissues in vivo (Folkman,
1974; Folkman et al., 1971; Gimbrone et
al., 1974; Phillips et al., 1976).
Although the mechanism by which the
tumour-derived angiogenic factor induces
capillary growth is not known, the overall
process involves endothelial-cell hyper-
trophy (McAuslan & Hoffman, 1979)
migration and proliferation (Cavallo et al.,
1973; (Aimbrone & Gullino, 1976; Aus-
prunk & Folkman, 1977). Attempts to
examine the mechanisms of TAF action
on endothelial cells in vitro have often
produced ambiguous results. For example,
some partially purified tumour extracts
may be mitogenic for endothelial cells in
vitro, but either do not induce capillary
growth in vivo (i.e. they are non-angio-
genic) (MeAuslan & Hoffman, 1979) or
their angiogenic capacity has not been
reported (Fenselau & Mello, 1976). Con-
versely other tumour extracts have been
reported to contain angiogenic activity
when assayed in vivo, but not to be mito-
genic for endothelial cells in vitro (Phillips
et al., 1976; Folkman & Contran, 1976).
More recently, a low-mol.-wt factor (ESF)
has been purified from sonicated tumour
cells grown in tissue culture and shown to
contain angiogenic activity in vivo, but not
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to be mitogenic for endothelial cells in
vitro (McAuslan & Hoffman, 1979). On the
basis of these observations, tumour ex-
tracts have been postulated to contain two
different factors, one which induces neo-
vascularization in vivo (ESF) while the
other stimulates endothelial-cell prolifera-
tion in vitro; the in vivo response to tumour
extracts could then be due to a combina-
tion ofthese factors (McAuslan & Hoffman,
1979; and Folkman in Kumar, 1980).
In a previous study we demonstrated
that a crude tumour extract containing
angiogenic activity in vivo was also
mitogenic for endothelial cells in vitro,
provided that the cells were growing on a
native collagen substrate in the presence
of platelet-release factors (Schor et al.,
1979). In the present communication we
report that a low-mol.-wt (LMW) com-
pound isolated from tumour extracts and
shown to be angiogenic in vivo (Weiss
et al., 1979) is also mitogenic for endo-
thelial cells on a native collagen substrate
in vitro. Since we have also been able to
obtain this factorfrom non-tumour sources
(Brown et al., 1980) we have called it
"endothelial-cell-stimulating angiogenesis
factor" (ESAF).
MATERIALS AND METHODS
Cells.-Endothelial cells (CBEC) were iso-
lated from cow brain white-matter capillaries
as previously described (Phillips et al., 1979).
Primary cultures were grown in 75cm2 tissue-
culture Falcon flasks in Medium 199 supple-
mented with 10mM L-glutamine, 100 i.u. of
penicillin and 100 jug streptomycin per ml
and 16% foetal calf serum (FCS).
Early-passage cultures of human embryo
and adult fibroblasts were obtained from
Dr D. Scott (Paterson Laboratories, Man-
chester).
Collagen substrates-.Type I collagen was
extracted from rat-tail tendons and used to
prepare heat-denatured collagen (gelatin)
films and 3-dimensional gels ofnative collagen
fibres in 35mm plastic Petri dishes (Gibco-
Biocult) as previously described (Schor &
Court, 1979).
Endothelial-cell-stimulating angiogenesisfac-
tor (ESAF).-Extracts of Walker 256 car-
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cinoma containing angiogenic activity (TAF)
when assayed on the chick chorioallantoic
membrane, were prepared as previously
described (Phillips et al., 1976; Phillips &
Kumar, 1979). An LMW compound ('200
daltons) with angiogenic activity (ESAF)
was subsequently isolated from the tumour
extract by affinity chromatography using
antibody prepared against crude TAF coupled
to Sepharose (Weiss et al., 1979). Certain
batches of ESAF were further purified by gel
filtration on P2 biogel (Weiss et al., 1979). The
structure of the LMW ESAF isolated in this
manner is currently under investigation. The
yield of purified material is very small, and
inert "fillers" (albumin or lactose) were
routinely added to facilitate handling. The
actual concentration of ESAF used in our
experiments is therefore not known, although
mass spectroscopy suggests that it is present
only in pg quantities. Each batch of ESAF
prepared in the above manner was tested for
its ability to induce blood-vessel growth in the
chick chorioallantoic membrane (Folkman,
1974; Phillips & Kumar, 1979) before being
used in the experiments in vitro.
Determination of cell proliferation.-Con-
fluent primary cultures ofCBEC were washed
twice with Dulbecco's phosphate-buffered
saline "A" (BSS) and then incubated for 20
min at 37°C with 8 ml of2mM ethyleneglycol-
bis (-aminoethyl ether) N,N'-tetraacetic acid
(EGTA) in BSS; trypsin (Difco-Bacto) was
then added to give a final concentration of
0.05% and the cultures incubated for a
further 5 min. The trypsin was neutralized
by the addition of foetal calf serum, the cells
collected by centrifugation at 200 g for 10
min and resuspended in Medium 199 con-
taining either 8% or 16% foetal calf serum.
Two-ml aliquots ofthe appropriate suspension
were added to the different substrates. The
number of cells plated on native collagen gels
was approximately double the number plated
on plastic dishes or gelatin films (see Results).
The cultures were incubated at 37°C in a
humidified 5% C02-95% air atmosphere.
Sixteen to 24 h after plating, the medium
was changed and ESAF dissolved in 100 ,ul
BSS was added to the appropriate cultures.
An equal volume of BSS was added to the
controls.
In the experiments lasting more than 3 days
the medium was changed and ESAF added
every 2-3 days.
The number ofcells in the different cultures
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was determined with a Coulter particle
counter. Cells growing on plastic or gelatin
films were removed for counting by trypsin
(0 25% trypsin for 10 min at 370C). Cells
growing on the 3 dimensional gels of native
collagen were not completely detached by
trypsin (Schor & Court, 1979) and, in order
to recover the cells, these cultures were first
treated with 1 ml of 0-2 mg/ml bacterial
collagenase (Sigma, C-2139) in Medium 199
for 4-5 h to dissolve the collagen gel and the
cells subsequently trypsinized and counted as
previously described (Schor et al., 1979).
Triplicate cultures were used for every
determination and the standard deviation
was always less than 10% of the mean. The
significance ofdifferences between means was
estimated by Student's t test.
RESULTS
Effect of ESAF on CBEC proliferation on
different substrates
The growth characteristics of the cow-
brain endothelial cells (CBEC) on plastic
tissue-culture dishes and native collagen
gels has been described (Schor et al., 1979).
Briefly, cell behaviour on the native
collagen gels differs from that on plastic
dishes with respect to attachment charac-
teristics (fewer cells remain attached to
the native collagen gels 24 h after seeding
a cell suspension) lag period before cell
growth begins (longer on the native col-
lagen gels) and growth rates (slower on
the native collagen gels). As a result of
the differences in the attachment and
growth characteristics of the cells on the
various substrates, twice as many CBEC
were routinely plated on the collagen gels
than on the plastic dishes in order to have
comparable cell numbers attached 2-3
days later. Cell behaviour on gelatin films
was similar to that on plastic for all the
parameters studied.
The effect of the purified, LMW ESAF
on the growth of CBEC on plastic dishes,
gelatin films and native collagen gels is
shown in Fig. 1. Cells in medium contain-
ing 16% FCS were plated on the different
substrates and 24 h later the medium
(with unattached cells) was discarded and
replacedwith 2 mloffreshgrowthmedium.
Days
FIG. 1. Effect of ESAF on CBEC prolifera-
tion on native collagen (A) denatured colla-
gen (B) or plastic culture dishes (C).
Abscissa: Incubation time.
CBEC suspended in 160% FCS-medium
were plated 105 cells/dish (A) or 5-6 x 104
cells/dish (B or C). 24 h later (Day 0 in
graph) the medium was removed and 2 ml
of fresh medium was added. Cultures then
received either 100 ,ul of BSS (0 0)
or 5 ,tg of "ESAF+filler" (Batch A-5)
dissolved in 100 ,ul of BSS (*0-0). On
Day 4 the medium was changed again and
ESAF or BSS added as before. The number
of cells was determined on triplicate cul-
tures. ESAF significantly increased cell
numbers only when the cells were growing
on native collagen (A): P < 0-01 on Days 2,
3 and 5; P<0-05 on Day 6.
The number of attached cells was deter-
mined (Day 0 in Fig. 1) and all cultures
then received either 100 ,ul of BSS alone
or 100 pl of BSS containing 5 Hg of ESAF
+filler. CBEC grew at a faster rate on
plastic tissue-culture dishes and gelatin
films than on native collagen gels. The
presence of ESAF did not further increase
the cell proliferation on plastic or gelatin
films, but did produce a significant in-
crease in cell growth on the collagen gels.
Under these conditions, ESAF did not
shorten the lag period before growth
began on collagen gels, nor did it have a
significant effect on the cell attachment to
the substrate, as estimated by the number
of cells present in the supernatant of
ESAF-treated and control cultures. The
final cell density was not affected by ESAF
(data not shown).
The effects ofdifferent concentrations of
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TABLE.-Growth stimulatory activity (GSA)
of ESAF on endothelial cells (CBEC)
cultured on native collagen gels
5 50 100 500 1000
FIG. 2.-Growth stimulation induced by dif-
ferent concentrations of ESAF on CBEC
cultures on plastic (A) and native collagen
(B).
CBEC were plated on plastic (A: 3 7 x
104 cells/dish) or native collagen (B: 7-5 x
104 cells/dish) in 2 ml 16% FCS-medium.
The number of cells attached 24 h later
was 1-4 + 0-02 x 104 cells/plastic dish and
2-0 + 0-09 x 104 cells/collagen dish. The
medium was changed at this point and
ESAF (Batch A-1) dissolved in 100 ,A
BSS was added at the concentration indica-
ted. The number ofcells in the cultures after
another 48 h of incubation is shown in the
graph.
ESAF
Batch no.
A-1*
A-2
A-3*
A-4
A-5*
A-6*
P-1
P-2
P-3
"ESAF +filler"
(Kg/ml))~~~~~~~-
GSA
0 5-500
25-50
2-5
2-5, 5
0-5-25
2-5-25
100
0 5
1
Range
tested
0 5-500
2-5-500
0-5-250
2-5, 5
0 5-50
0 05-50
0-5-200
0 05-5
0-05-15
Maximum
stimulation
induced (%
increase
over the
controls)
139
89
58
31
166
77
31
61
100
A low-mol.-wt angiogenic factor (ESAF) was
isolated from rat Walker 256 carcinoma extracts by
affinity chromatography ("A-" batches) and further
gel filtration ("P-" batches) (Weiss, et al., 1979).
The actual concentration of ESAF is not known
since an inert filler (albumin or lactose) was added to
facilitate handling (see Methods). GSA was estimated
by the increase in cell numbers in cultures of CBEC
incubated with ESAF for 48-72 h. All ESAF batches
were tested on cultures in plastic and native collagen;
batches marked * were also tested on denatured
collagen. GSA was apparent on native collagen only.
ESAF on cell growth are shown in Fig. 2.
In this experiment, cells were placed on
the different substrates and the medium
changed after 24 h. The number of cells
attached to the different substrates was
then determined and all cultures received
either 100 pl ofBSS alone or BSS contain-
ing different amounts of ESAF. The
cultures were then incubated at 37TC and
cell numbers determined after 48 h. As can
be seen in Fig. 2, no concentration of
ESAF produced an increase in cell number
on plastic dishes; the same results were
also obtained with cells growing on gelatin
films (not shown). However, when the
cells were cultured on collagen gels, ESAF
stimulated cell growth. A bell-shaped
dose-response curve was obtained; in this
case maximum stimulation was produced
with 5 ,g ESAF +filler/dish.
Results similar to those presented in
Fig. 2 have been obtained with all the
batches of ESAF tested and are sum-
marized in the Table. The number of cells
in the different cultures was determined
48-72 h after the addition of ESAF. The
concentrations of ESAF producing growth
stimulation usually fell within a narrow
range. No effect of ESAF on cell prolifera-
tion onplastic orgelatin was everobserved.
It should be noted that the actual con-
centration of ESAF used in these experi-
ments was not known, as there was in-
sufficient for weight determination and
inert "fillers" (albumin or lactose) were
used.
ESAF stimulated CBEC proliferation in
growth medium containing either 8% or
16% FCS when the cells were cultured on
native collagen, but not on plastic or
denatured collagen. In the experiment
showninFig. 3, the stimulation inducedby
5 ,tg ESAF + filler/dish was more marked
in 16% than in 8% FCS (P<001). The
other concentrations of ESAF produced a
similar increase in cell numbers irrespec-
tive of the serum concentration. Control
experiments indicated that second passage
CBEC which had been grown to confluence
on native collagen (Schor et al., 1979)
behaved as first-passage cells in growth
characteristics and response to ESAF, and
5
4-
'4 3-
x 2-
1-
. . . I
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FIG. 3.-Growth-stimulatoryactivityofESAF
on CBEC in 8% or 160, serum concentra-
tion.
CBEC (1.1 x 105 cells/dish) were plated
on native collagen in 8o% or 160% FCS-
medium. 24 h later the mediumwaschanged,
the cells counted (shaded blocks) and ESAF
(Batch A-5) added in the concentration
shown. The cells in the different cultures
were counted again 48 h after addition of
ESAF (open blocks). 1, 5 and 50 fig "ESAF
+filler"/dish stimulated cell growth (P <
0-01); 100 fig/dish did not. Stimulation by
5 fig was greater with 16% than with 8%
FCS (P < 0-01). Cells plated on denatured
collagen or on plastic and treated in the
same way were not stimulated to proliferate
(not shown).
that the filler alone (albumin or lactose)
had no effect on cell proliferation.
Role of the substrate in the CBEC response
to ESAF
The mechanism by which ESAF stimu-
lates CBEC proliferation in collagen gels
is not understood. The following experi-
ments were performed in order to deter-
mine whether cell proliferation is affected
by the interaction of either ESAF or
serum factors with the substrate.
The effects of preincubating the gels
with serum are shown in Fig. 4. Collagen
gels were incubated with either serum-free
medium or medium containing 16% FCS
for 24 h and then extensively washed by 6
changes of 2 ml BSS over a period of 24 h.
CBEC in medium containing 8%0 serum
A B C
2-
05 0 5 0 0 5
ESAF+fifer I i'iiSh )
FIG. 4. Growth-stimulatory activity of
ESAF on CBEC growing at different rates
on native collagen.
CBEC in 8% FCS-medium were plated
on collagen gels pre-incubated with serum-
free medium (A: 9-8 x 104 cells/dish), on
gels pre-incubated with 160o FCS-medium
(B: 9-8 x 104 cells/dish) or on plastic dishes
(C: 5 x 104 cells/dish). 24 1 later the number
of cells attached was determined (shaded
blocks); the medium was changed and 5 ,ug
of "ESAF+filler" (Batch A-3) in BSS (or
BSS alone) were added. The cultures were
returned to the incubator and the cells
counted 48 h later (open blocks).
was plated on these collagen gels and on
plastic dishes. The medium on all cultures
was changed 24 h later and replaced with
fresh medium containing 8% FCS. Cell
number was determined and all cultures
then received 100 pl of BSS or BSS con-
taining 5 /tg of ESAF +filler. Cultures
were incubated at 37°C and cell numbers
determined after 48 h. As can be seen in
Fig. 4, cell proliferation was greater on the
gels pre-incubated with medium contain-
ing 16% FCS than on gels treated with
serum-free medium. ESAF stimulated
CBEC proliferation when the cells were
growing on native collagen gels, irrespec-
tive of whether the growth rate was low
(serum-free pre-incubated gels) or high
(16% serum pre-incubated gels). Cultures
!.;i I I .1 I
I
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FIG. 5.-Growth-stimulatory activity
ESAF pre-incubated on different substr
Before seeding the cells, 1/6 of the d
to be used (plastic, native and denat
collagen substrates) were incubated
2 ml ofserum-free medium containing
"ESAF +filler" (Batch A-6) per dish.
remaining dishes were incubated with
of serum-free medium. After 24 h at
all dishes were washed x 8 with 2 ml
over a 20 h period. CBEC suspended in
FCS medium were then plated on to ni
collagen gels (105 cells/dish). 16 h late
number of cells attached was ( x
3 50+018x104 and 3-53+0-17x10
gels that had been pre-incubated wit
without ESAF respectively (Day 0 ir
graph). The medium with non-attached
was then removed, 2 ml of fresh 16%
medium were added per dish and the
ferent cultures received 100 pl BSS or 1
"ESAF+filler" (Batch A-6) in 100 ,ul
The solutions ofESAF had either been
at - 20C orhadbeenpre-exposed toplh
native and denatured collagen by incu
ing 400 ,tg "ESAF + filler" per dish or
different substrates for 24 h before use
text).
Controls (0) and gels pre-incub
with ESAF (0) received 100 lzl BSS.
remaining cultures received an ESAF
tion which had either been kept at -
(*) or had been pre-exposed to nf
collagen (A) to plastic (A) or to denat
collagen (not shown). Cell growth on p1
and denatured collagen (not shown) wa,
growing on plastic or gelatin films (not
shown) were not stimulated by ESAF
oe, under the same conditions.
The results obtained in a similar experi-
ment in which gels were preincubated with
ESAF rather than serum are shown in
Fig. 5. In this case, solutions of "pre-
exposed" ESAF were prepared by incubat-
ing dishes containing the different sub-
strates with a high concentration of
ESAF in BSS for 24h; this ESAFwasthen
collected, diluted to the appropriate
concentration (assuming no ESAF had
been lost during the incubation) and stored
at - 20°C until required. Substrates were
thenprepared by incubating plastic dishes,
gelatin films and native collagen gels for
24 h at 37°C witheitherserum-free medium
or serum-free medium containing 10 jug
of a particular batch of ESAF+filler (a
concentration previously shown to stimu-
3 late cell growth on collagen gels). All
substrata were then washed x 8 with
BSS over a 20hperiod. CBECin 16%serum
medium were plated in these substrates
fates. and incubated for a further 16 h. The
tishes medium was changed andthecellsattached
tured to samples of all the substrates counted
1ith (Day 0). At this point cultures on sub-
The strates preincubated with serum-free
2 ml mediumreceivedeither 100 plofBSS alone
370C
BSS (controls), 100 ulof BSS containing 10 tg
16% ESAF+filler (the same concentration ative used to pre-incubate the gels) or BSS ~rtheto ter
< 104) containing 10 Htg of ESAF+filler pre-
4 on viously exposed to either plastic dishes,
nther gelatin films or native collagen gels. Cells
Icells growing on substrates preincubated with
FCS- ESAF received 100 [lI of BSS only, with dif-
L0 jug no additional ESAF. All cultures were
BSS. then incubated for 3 more days. Cells
kept growing in plastic dishes or gelatin films astic,
ibat- were not stimulated to grow more than
a the the controls by ESAF in any of the
(see
ated same in all cultures. On native collagen the
The number ofcells present ingels that had been
solu- pre-incubated with ESAF (0) was sig-
200C nificantly higher than in the controls (*) on
ative Days 1, 2 and 3 (P < 0-01). Addition of the
;ured different ESAF solutions (A, A, M) increa-
Lastic sed the cell numbers on Days 2 and 3
,s the (P < 0-01).
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conditions tested (data not shown). On
native collagen gels, addition of t,he dif-
ferent ESAF solutions or preincubation
of the gels with ESAF produced a similar
increase in cell numbers after 3 days of
incubation. In this particular experiment
no lag period was observed on gels pre-
incubated with ESAF, though this may
be because cells on these gels had been in
contact with it for 16 h when ESAF was
added to the remaining cultures. In other
experiments we have found that pre-
incubation of the gels with ESAF does
not shorten the lag period. These data
indicate that ESAF binds to collagen and
can stimulate CBEC proliferation in this
state. Binding was not prevented by pre-
incubation of the gels with l6% FCS
before incubation with ESAF, and ESAF
remained on the gels after extensive wash-
ing with BSS (for up to 48 h) or with 05m
PBS (6 x 2ml) for 5 h.
The effects of ESAF pre-exposed to
different substrates on CBEC proliferation
suggest that it is not inactivated by
exposure to plastic or denatured collagen,
and that the cells must actually be growing
on a native collagen substrate for ESAF to
stimulate cell growth. This conclusion is
consistent with the results obtained in
other experiments in which ESAF had no
effect on CBEC growing on plastic dishes
with a collagen gel floating in the medium
above the cells (data not shown). The
floating collagen gels were either pre-
incubated with ESAF or ESAF was added
to the cultures at the same time as the gel.
Effect of ESAF onfibroblasts
Human enibryo and adult skin fibro-
blasts showed no response to ESAF when
tested under the same conditions as
CBEC (data not shown).
DISCUSSION
We have previously reported (Schor
et al., 1979) that the effect of TAF-
containing tumour extracts on endothelial
cells in vitro follows one of two patterns:
1. If the tumour extract was not trypsin-
ized during the extraction procedure
it would stimulate endothelial-cell (and
fibroblast) proliferation both on plastic
and native collagen substrates.
2. If the extraction was trypsinized it
would stimulate endothelial cell pro-
liferation only when the cells were
cultured on native collagen and in the
presence of platelet-released factor.
Fibroblasts were not stimulated.
In view of the results presented here
one can speculate that human platelet
factors may act enzymatically upon TAF-
containing tumour extracts, perhaps re-
leasing an LMW angiogenic factor (ESAF)
from a carrier protein. Trypsin, on the
other hand, may destroy growth factors
other than ESAF without affecting the
latter.
ESAF is angiogenic when assayed on
the chick chorioallantoic membrane (Weiss
et al., 1979) and we have shown that it
stimulates endothelial-cell (CBEC) pro-
liferation on native collagen gels in vitro
without addition ofhuman platelet factors
to the cultures. Unlike some TAF-
containing tumour extracts (Schor et al.,
1979) ESAF does not stimulate fibroblast
growth.
The data presented in Fig. 3 indicate
that the response of the endothelial cells
to ESAF can be influenced by the con-
centrations of serum in the medium. We
are currently investigating whether this
effect is due to bovine platelet factors in
the serum. It has been shown, however,
that growth factors derived from human
serum and platelets are immunologically
different from bovine serum factors (Anto-
niades & Scher, 1978).
The stimulation of CBEC proliferation
on native collagen gels in vitro by all of
the batches of ESAF tested (9 in total)
shows a similar bell-shaped dose-response
curve. CBEC cultured on either plastic
culture dishes or denatured collagen films
showed no response to ESAF under any
of the conditions tested.
The concentration of ESAF which
796ANGIO1 ENESIS FACTOR END)OTHELIAL (CELL STIMULATION
induces the m-iiaximiial response is niot
yet known since the amounts obtaiined
were so small that weighing was not
feasible. The incorporation ofinert "fillers"
during the ESAF extraction procedure
facilitated its handling. The amount of
ESAF which stimulated endothelial-cell
proliferation was between 1/100 to 1/1,000
the amount used to detect angiogenic
activity in the chick choriollantoic nmem-
brane assay.
Although fewer cells remain attached to
the collagen gels than to the plastic dishes
24 h after plating, it is unlikely that an
ESAF-sensitive subpopulation of cells is
selected, since stock cultures of CBEC
growxv on collagen gels show exactly the
same growtlh characteristics and response
to ESAF when subsequently cultured on
plastic dishes acnd collagen gels as reported
here.
ESAF does not affect cell attachment to
the substratum.
Why a native collagen substrate is
required for ESAF to stimulate CBEC'
proliferation is not known. Our results
suggest that the slower growth rate on
native collagen than on denatured col-
lagen or plastic is due to adsorption of
serum growth factors to the gel. By
manipulating the serutm concentration
available to the cells or pre-incubating the
gels with serum-containing medium, CBEC
could be grown at similar rates on plastic
and native collageni, and our results show
that stimulation of cell growth by ESAF
occurs only on native collagen substrates,
independently on the growth rate of the
control cultures.
Unlike stimultaion by increasing serum
concentrations, ESAF-stimulated and un-
stimulated cultures reached the same cell
saturation density. Lack of stimulation
by ESAF of cultures on plastic and gelatin
does not appear to be due to inactivation
of ESAF on those substrates, since ESAF
pre-exposed to plastic or gelatin was still
active.
ESAF binds to native collagen, and this
may be a crucial step on its mode ofaction.
Our data show that ESAF-bound collagen
stimulates cell proliferation onlywhen used
as the substrate for the cells. ESAF bound
to collagen was not removed by extensive
washing with 0-5M PBS, thus the binding
does not seem to be a simple electrostatic
attachment.
The importance of the extracellular
matrix in cell behaviour is widely recog-
nized. Collagen is a major constituent of
the extracellular matrix and it has been
shown to affect cell attachment (Schor &
Court, 1979; Klebe, 1975; Murray et al.,
1979) proliferation (Liotta et al., 1978;
Schor, 1980; Rath & Reddi, 1979; Gey
et al., 1974; Ehrman & Gey, 1956)
migration (Algire & Chalkley, 1945;
Kadish et al., 1979), differentiation (Reddi
& Anderson, 1976; Meier & Hay, 1975;
Konigsberg & Hauschka, 1965) morpho-
logy (Gospodarowicz et al., 1978) and
collagen biosynthesis (Meier & Hay, 1974).
New formation of collagen, as well as
neovascularization, are required for con-
tinuous tumour growth; both the tumour-
associated collagen and blood vessels are
produced by the host (Folkman 1974;
Gullino, 1973). It is therefore possible
that a native collagen substrate allows
the CBEC to react to ESAF as they
would in vivo, whereas more artificial
substrates such as plastic or denatured
collagen do not. Chemical identification
of the many angiogenic factors reported
in the literature (Folkman et al. 1971;,
Phillips et al., 1976; McAuslan & Hoffman,
1979; Polverini et al., 1977; Wolf &
Harrison, 1973; Klagsburn et al., 1976;
Auerbach et al., 1976; Huseby et al.,
1975; Maiorana & Gullino, 1978; Tsuka-
moto & Sugino, 1979; Gospodarowicz &
Thakral, 1978) including our own will
determine whether they are the same.
Published data suggest that TAF is a
unique tumour marker (Algire & Chalkley,
1945; Folkman, 1974; Phillips et al., 1976;
Maiorana & Gullino, 1978) but it may be
the same as other angiogenic factors, pos-
sibly common to all tissue capable of
growth and repair, its concentration
related to the metabolic activity of the
tissue. It is worth pointing out that the
797798 A. M. SCHOR ET AL.
angiogenic factor used in our experiments
(ESAF) was in fact tumour-derived. It
will be interesting to know whether the
reported lack of stimulatory activity by
other purified angiogenic factors when
tested on endothelial cells in vitro
(MeAuslan & Hoffman, 1979; Folkman,
in Kumar, 1980) does also apply when the
cells are cultured on native collagen, and
whether endothelial cells derived from
capillaries and from large vessels can be
stimulated in a similar way by ESAF in
culture.
This work was supported by the Cancer Research
Campaign.
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